These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 10077770)

  • 21. Development and evaluation of a DNA vaccine based on Helicobacter pylori urease B: failure to prevent experimental infection in the mouse model.
    Zavala-Spinetti L; Breslin MB; Correa H; Bégué RE
    Helicobacter; 2006 Dec; 11(6):517-22. PubMed ID: 17083372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A vaccine against Helicobacter pylori: towards understanding the mechanism of protection.
    Aebischer T; Walduck A; Schroeder J; Wehrens A; Chijioke O; Schreiber S; Meyer TF
    Int J Med Microbiol; 2008 Jan; 298(1-2):161-8. PubMed ID: 17702653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perspectives of anti-H. pylori vaccination.
    Saldinger PF; Blum AL; Corthésy-Theulaz IE
    J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():59-65. PubMed ID: 9440056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helicobacter pylori vaccine strategies--triggering a gut reaction.
    Hatzifoti C; Wren BW; Morrow WJ
    Immunol Today; 2000 Dec; 21(12):615-9. PubMed ID: 11114421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation, immunity, vaccines for Helicobacter infection.
    Chmiela M; Michetti P
    Helicobacter; 2006 Oct; 11 Suppl 1():21-6. PubMed ID: 16925607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The development of therapeutic and preventive vaccines for gastric cancer and Helicobacter pylori.
    Chui SY; Clay TM; Lyerly HK; Morse MA
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1883-9. PubMed ID: 16103431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic immunization with unadjuvanted whole Helicobacter pylori protects mice against heterologous challenge.
    Harbour SN; Every AL; Edwards S; Sutton P
    Helicobacter; 2008 Dec; 13(6):494-9. PubMed ID: 19166414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammation, immunity, and vaccines for Helicobacter pylori.
    D'Elios MM; Andersen LP
    Helicobacter; 2009 Sep; 14 Suppl 1():21-8. PubMed ID: 19712164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen.
    Inoue K; Shiota S; Yamada K; Gotoh K; Suganuma M; Fujioka T; Ahmed K; Iha H; Nishizono A
    Helicobacter; 2009 Oct; 14(5):135-43. PubMed ID: 19751439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review article: Helicobacter pylori vaccines-the current status.
    Sutton P; Lee A
    Aliment Pharmacol Ther; 2000 Sep; 14(9):1107-18. PubMed ID: 10971226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The current status of Helicobacter pylori vaccines: a review.
    Kabir S
    Helicobacter; 2007 Apr; 12(2):89-102. PubMed ID: 17309745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a mouse model of Helicobacter pylori infection that mimics human disease.
    Marchetti M; Aricò B; Burroni D; Figura N; Rappuoli R; Ghiara P
    Science; 1995 Mar; 267(5204):1655-8. PubMed ID: 7886456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis.
    McGuckin MA; Every AL; Skene CD; Linden SK; Chionh YT; Swierczak A; McAuley J; Harbour S; Kaparakis M; Ferrero R; Sutton P
    Gastroenterology; 2007 Oct; 133(4):1210-8. PubMed ID: 17919495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of vaccines against Helicobacter pylori.
    Del Giudice G; Malfertheiner P; Rappuoli R
    Expert Rev Vaccines; 2009 Aug; 8(8):1037-49. PubMed ID: 19627186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clearance of Helicobacter pylori infection through immunization: the site of T cell activation contributes to vaccine efficacy.
    Blanchard TG; Eisenberg JC; Matsumoto Y
    Vaccine; 2004 Feb; 22(7):888-97. PubMed ID: 15040942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses.
    Nyström J; Svennerholm AM
    Vaccine; 2007 Mar; 25(14):2591-8. PubMed ID: 17239498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. gammadelta T cells increase with gastric mucosal interleukin (IL)-7, IL-1beta, and Helicobacter pylori urease specific immunoglobulin levels via CCR2 upregulation in Helicobacter pylori gastritis.
    Futagami S; Hiratsuka T; Suzuki K; Kusunoki M; Wada K; Miyake K; Ohashi K; Shimizu M; Takahashi H; Gudis K; Kato S; Tsukui T; Sakamoto C
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):32-40. PubMed ID: 16706809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards the development of vaccines against Helicobacter pylori: status and issues.
    Del Giudice G
    Curr Opin Investig Drugs; 2001 Jan; 2(1):40-4. PubMed ID: 11527009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection.
    Shi T; Liu WZ; Gao F; Shi GY; Xiao SD
    Helicobacter; 2005 Feb; 10(1):71-9. PubMed ID: 15691317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective anti-Helicobacter immunity is induced with aluminum hydroxide or complete Freund's adjuvant by systemic immunization.
    Gottwein JM; Blanchard TG; Targoni OS; Eisenberg JC; Zagorski BM; Redline RW; Nedrud JG; Tary-Lehmann M; Lehmann PV; Czinn SJ
    J Infect Dis; 2001 Aug; 184(3):308-14. PubMed ID: 11443556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.